Table 1. Clinical and demographic characteristics of the study population at the baseline.
| Variable | Glucose Group n=15 |
Icodextrin Group n=15 |
Overall | p value | ||
|---|---|---|---|---|---|---|
| Demographic | ||||||
| Age (years) | 56.5±16.1 | 56.1±15.3 | 56.3±15.4 | 0.94 | ||
| Sex (male) | 7 (46.7) | 3 (20) | 10 (33.3) | |||
| Etiology of chronic Kidney disease [n (%)] | 0.58 | |||||
| Diabetes | 6 (40) | 3 (20) | 9 (30) | |||
| Hypertension | 2 (13.3) | 5 (33.3) | 7 (23.3) | |||
| Glomerulonephritis | 1 (6.7) | 2 (13.3) | 3 (10) | |||
| Others | 2 (13.3) | 2 (13.3) | 4 (12.3) | |||
| Unknown | 4 (26.7) | 3 (20) | 7 (23.3) | |||
| Clinical | ||||||
| Dialisate/Plasma creatinine [n (%)] | 0.18 | |||||
| High | 3 (23.1) | 7 (58.3) | 10 (40) | |||
| High average | 8 (61.5) | 3 (25) | 11 (44) | |||
| Low average | 2 (15.4) | 2 (16.7) | 4 (16) | |||
| Kt/V (total) | 1.80±0.53 | 2.28±0.82 | 2.0±0.7 | 0.07 | ||
| Kt/V (renal) | 0.43(0-0.84) | 0.75(0.14-1.01) | 0.54 (0-0.98) | 0.16 | ||
| Systolic blood pressure (mmHg) | 138.5±22.8 | 148.4±25.5 | 143.5±24.3 | 0.27 | ||
| Diastolic blood pressure (mmHg) | 77.1±16.3 | 85.3±16.8 | 81.2±16.8 | 0.19 | ||
| Extracellular water (L) | 20.5±5.0 | 23.4±11.5 | 22.0±8.8 | 0.36 | ||
| Ultrafiltration (L) | 1134±611 | 1083±530 | 1112±565 | 0.82 | ||
| Residual kidney function (ml) | 805 (0–1500) | 352(0–500) | 762 (0–1000) | 0.10 | ||
| Use of medications [n(%)] | 0.08 | |||||
| Loop diuretics (furosemide)* | 15 (100) | 15 (100) | 30 (100) | |||
| Diuretics | 3 (20) | 3 (20) | 6 (20) | |||
| ACEI + Diuretics | 7 (46) | 6 (40) | 13 (43.3) | |||
| ACEI + Diuretics + CCB | 5 (33) | 4 (36) | 9 (30) | |||
| ACEI + Diuretics + BB | - | 2 (13.3) | 2 (6.7) | |||
| Phase angle (°) | 5.08 ± 1.36 | 5.04 ±1.12 | 5.51±1.34 | 0.83 | ||
*
Dose of 160 to 320mg/day.
ACEI: angiotensin-converting enzyme inhibitor; CCB: calcium channel blocker; BB: beta-blocker.